Astute Medical Obtains $13,000,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94d86c33-c4d8-4380-8ebe-d3f4ea1f45c2&Preview=1 -
Date
3/8/2011 -
Company Name
Astute Medical -
Mailing Address
3550 General Atomics Court San Diego, CA 92121 -
Company Description
Astute Medical’s mission is to identify and validate protein biomarkers of severe acute disease.Our focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Our emphasis is on patients who present to the emergency department with acute symptoms and hospitalized patients who are at risk for an acute event. -
Website
http://www.astutemedical.com -
Transaction Type
Venture Equity -
Transaction Amount
$13,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products. -
M&A Terms
-
Venture Investor
Domain Associates -
Venture Investor
Delphi Ventures -
Venture Investor
De Novo Ventures -
Venture Investor
Johnson & Johnson Development Corporation
